ANGO - AngioDynamics Operating income before deduction of amortization
AngioDynamics, Inc. (ANGO) EBITDA reflects a struggle for physician trust amid pressure from agile startups, with the metric currently standing at 2.88. High capacity utilization and the implementation of automated quality control ensure stability. Global shipments of cardiology and oncology tools to hundreds of clinics reliably shield the company from local regulatory risks.
Summary analytical data breakdowns for AngioDynamics (ANGO)
- stock quotes and analyst forecast:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
Aggregate Debt to Capital AngioDynamics, Inc.|ANGO - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AngioDynamics Inc|ANGO - Company Total Debt|Debts to Book Capitalization AngioDynamics|ANGO - Company Long-Term Debt|Company Current Liabilities AngioDynamics|Immediate Liquidity angiodynamics.com
- earnings and valuation multiples indicators:
ANGO - Company Net Income|Net Profit Forecast AngioDynamics, Inc.|ANGO - Price to Earnings Ratio|Market Cap to Future Earnings Ratio angiodynamics.com|ANGO - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio AngioDynamics|ANGO - Operating profit EBITDA|Net earnings per share (EPS TTM) AngioDynamics|ANGO - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months angiodynamics.com|ANGO - Earnings growth in current year|Net earnings per one share growth forecast for next year AngioDynamics, Inc.
Fundamental company valuation:ANGO (AngioDynamics Inc.)
Daily liquidity inflows from core operations determine the resilience of AngioDynamics, Inc. (ANGO) to market volatility, reflecting the actual cash balance remaining after operating expenses. Against the backdrop of device portfolio optimization and debt reduction, the EBITDA_Co chart confirms the effectiveness of the transition to high-margin products, allowing investors to objectively assess the speed of cash generation and the pace at which the company is reaching stable net profit.
Competitors of AngioDynamics, Inc. (ANGO)
Income before deduction of interest, taxes and amortization ISRG|Danaher Corp. - Operating profit EBITDA|Operating income before deduction of amortization bd.com BDX|STERIS (STE) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WST|Profit before payment of interest, taxes and amortization Baxter Corp|Masimo Inc. (MASI) - Operating income before deduction of amortization|Operating profit before deduction of amortization STVN (Stevanato Group S.p.A.)|Company profit before taxes, interest and amortization TFX|Profit before payment of interest, taxes and amortization Merit Medical MMSI|Income before deduction of interest, taxes and amortization NVST|ICUI: Operating profit before deduction of amortization|XRAY - Operating profit EBITDA|LeMaitre Vascular, Inc. (LMAT) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization atricure.com|STAA (STAAR Surgical) - Operating profit EBITDA|Profit before interest, taxes and amortization ChromaDex Corp NAGE|Profit before payment of interest, taxes and amortization ZimVie Dental (ZIMV)|Cerus Inc - Operating profit before amortization|Alpha Teknova, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization MGRM (monogramorthopedics.com)|STSS - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization InfuSystem Holdings INFU|UTMD: Operating profit EBITDA|KORU Medical (KRMD) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Nyxoah S.A.|Operating profit before amortization MBOT (microbotmedical.com)|Operating profit EBITDA PDEX|Zentek Ltd (ZTEK) - Operating profit before depreciation charges|Operating profit EBITDA ELUT (Elutia Corp)|Operating income before deduction of amortization Milestone Scientific Corporation (MLSS)|NXGL - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Retractable Technologies|HBIO: Operating profit EBITDA|Operating profit before amortization FEMY|Operating profit before deduction of amortization MHUA|Profit before interest, taxes and amortization Predictive Oncology Corp POAI|Profit before payment of interest, taxes and amortization Callan JMB Inc (CJMB)|atrioncorp.com - Operating profit before amortization|Operating profit EBITDA NURO (NeuroMetrix)
